Autolus Therapeutics plc ADR (NASDAQ: AUTL) is -12.77% lower on its value in year-to-date trading and has touched a low of $1.11 and a high of $5.00 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The AUTL stock was last observed hovering at around $2.12 in the last trading session, with the day’s loss setting it -0.07%.
Currently trading at $2.05, the stock is 7.39% and 31.09% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.75 million and changing -3.30% at the moment leaves the stock -19.56% off its SMA200. AUTL registered -52.76% loss for a year compared to 6-month loss of -29.31%.
The stock witnessed a 58.91% gain in the last 1 month and extending the period to 3 months gives it a 12.64%, and is -12.77% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.24% over the week and 4.53% over the month.
Autolus Therapeutics plc ADR (AUTL) has around 647 employees, a market worth around $545.59M and $9.01M in sales. Profit margin for the company is -2642.69%. Distance from 52-week low is 85.52% and -59.00% from its 52-week high. The company has generated returns on investments over the last 12 months (-35.06%).
The EPS is expected to shrink by -4.39% this year.
Autolus Therapeutics plc ADR (AUTL) Top Institutional Holders
The shares outstanding are 266.14M, and float is at 240.33M with Short Float at 4.81%.
The top institutional shareholder in the company is SYNCONA PORTFOLIO LTD with over 21.35 million shares valued at $74.29 million. The investor’s holdings represent 8.0243% of the AUTL Shares outstanding. As of 2024-06-30, the second largest holder is BLACKSTONE INC. with 20.49 million shares valued at $71.29 million to account for 7.7006 of the shares outstanding. The other top investors are WELLINGTON MANAGEMENT GROUP LLP which holds 17.89 million shares representing 6.7248% and valued at over $62.26 million, while DEEP TRACK CAPITAL, LP holds 5.7409 of the shares totaling 15.27 million with a market value of $53.15 million.
Autolus Therapeutics plc ADR (AUTL) Insider Activity
#####